Insilico Medicine’s AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy

In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade, has made remarkable advances.

Pharmalittle: We’re reading about the Cencora data breach, a failed pandemic treaty, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was extended on this side of the pond thanks

May 28, 2024

Apple adding sleep apnea feature to smartwatch

Dive Brief: Apple plans to add sleep apnea notifications to its smartwatch this month, equipping the device to detect breathing disturbances. The new Apple Watch

September 10, 2024

Genetic link identified between inflammatory bowel disease and Parkinson’s disease

The researchers found, as expected from prior studies that LRRK2 is associated with IBD-PD and discovered new associations as well.

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.